ProQR Therapeutics develops RNA editing medicines for liver and nervous system diseases using its Axiomer platform. It last closed at $1.15 on Nov 17, down 2.54% on the day. The average 12-month price target from 3 analysts is $6.33 (+450.7% from the last close), with a high of $8.00 and a low of $3.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
From PRQR's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 12). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
Each firm's latest rating on PRQR in the past 90 days
Average 12-month target
$6.33
▲ 450.7% upside
Based on 3 analysts who set a price target on PRQR in the past 90 days. The average target is $6.33, with a high of $8.00 and a low of $3.00, compared with the last close of $1.15.
Low $3.00Avg $6.33High $8.00
Blue marker: last close $1.15
Highest target$8.00
Average target$6.33
Lowest target$3.00
Latest rating changes
Chardan CapitalMaintained
Oct 1Buy$3
HC Wainwright & Co.Maintained
Oct 1Buy$8
B of A SecuritiesInitiated
Aug 20Buy$8
Evercore ISI GroupMaintained
Jun 29Buy$6
Jones TradingMaintained
Jun 26Buy$10
Date
Firm
Action
Rating
Price target
Oct 1
Chardan Capital
Maintained
Buy
$3
Oct 1
HC Wainwright & Co.
Maintained
Buy
$8
Aug 20
B of A Securities
Initiated
Buy
$8
Jun 29
Evercore ISI Group
Maintained
Buy
$6
Jun 26
Jones Trading
Maintained
Buy
$10
Loading…
Technical Analysis
PRQR · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 16% below its 20 day and 34% below its 50 day average. It is 45% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the 52 week low at $1.12, and the nearest resistance the Pivot at $1.16.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 9.1%/day
Key levels
$2.4952 week high+116.5%
$1.73100 day average+50.4%
$1.67200 day average+45.2%
$1.5450 day average+33.9%
$1.45Swing high (Nov 5)+26.1%
$1.3320 day average+15.7%
$1.20Pivot R1+4.3%
$1.16Pivot+0.9%
$1.15Last close
$1.1252 week low−2.6%
$1.11Pivot S1−3.5%
Indicators
RSI (14)
35.42
Weak, oversold below 30
Neutral
MACD
-0.08
Below its signal line
Bearish
Stochastic
26.5
Middle of its range
Neutral
ADX (14)
31.0
Trending down
Williams %R
-92.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-245.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−16.1%
Change over 10 sessions
Bearish
ATR (14)
$0.10
Typical daily range, 9.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 23.0%/day
Key levels
$2.4952 week high+116.5%
$1.73100 day average+50.4%
$1.67200 day average+45.2%
$1.5450 day average+33.9%
$1.45Swing high (Nov 5)+26.1%
$1.3320 day average+15.7%
$1.20Pivot R1+4.3%
$1.16Pivot+0.9%
$1.15Last close
$1.1252 week low−2.6%
$1.11Pivot S1−3.5%
Indicators
RSI (14)
35.85
Weak, oversold below 30
Neutral
MACD
-0.13
Below its signal line
Bearish
Stochastic
10.3
Near the bottom of its range
Oversold
ADX (14)
15.2
No clear trend
Williams %R
-97.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-134.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−38.2%
Change over 10 sessions
Bearish
ATR (14)
$0.26
Typical daily range, 23.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PRQR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PRQR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow PRQR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How PRQR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRQR is in one of them and how their past PRQR trades turned out.
ProQR is a biotechnology company based in Leiden, Netherlands, that develops RNA editing medicines. It uses its proprietary Axiomer platform, which directs enzymes already present in cells to make precise changes in RNA, to build treatments for diseases of the liver and central nervous system. Its lead candidate is in a Phase 1 trial in healthy volunteers, and its pipeline also covers Rett syndrome, MASH, a liver disease, and cardiovascular disease. The company also works with Eli Lilly on drug targets under a licensing and research collaboration.